Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anti-Light Shield 509
- Development stage
- Unknown
- Lead developer
- JALA Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Anti-Light Shield 509 (逆光盾509) is a proprietary botanical complex developed by Chando Group and JAK Technology, consisting of tea seed oil, tea extract, and Terminalia chebula fruit extract. It is designed for Asian skin photoprotection, hydration, and skin barrier integrity. The complex acts by downregulating miR-509-5p expression, which is upregulated upon ultraviolet radiation (UVR) exposure. By suppressing miR-509-5p, Anti-Light Shield 509 restores the expression of Hypoxia-Inducible Factor-1α (HIF-1α), a key regulator involved in epidermal renewal, barrier repair, and protection against oxidative stress. It is incorporated into Chando Group's Spring Summer (春夏) sunscreen product line to prevent photoaging.
- Brand names
- Anti-Light Shield 509逆光盾509
- Other names
- tea seed oil + tea extract + Terminalia chebula fruit extracttea seed oil, tea extract and Terminalia chebula fruit extract botanical complex
02
Targets
HIF1A (Hypoxia-inducible factor 1-alpha)miR-509-5p (microRNA-509-5p)
Beyond the preview
Go deeper on Anti-Light Shield 509.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anti-Light Shield 509.